Skip to main content
Top
Published in: Lung 3/2007

01-05-2007 | ORIGINAL PAPER

Association of HLA Class II Genes with Idiopathic Pulmonary Arterial Hypertension in Koreans

Authors: Sung-Ho Yoon, Heung-Bum Oh, Hyun-Kuk Kim, Suk-Chan Hong, Yeon-Mok Oh, Dong Soon Lee, Sang-Do Lee

Published in: Lung | Issue 3/2007

Login to get access

Abstract

The aim of this study was to compare the frequency of the HLA-DRB1 and HLA-DQB1 alleles in Korean patients with idiopathic pulmonary arterial hypertension (IPAH) and in normal controls and to determine any association that may exist between clinical characteristics of IPAH and specific HLA alleles. IPAH patients seen between October 1998 and September 2001 were retrospectively assessed, and 19 patients and 193 controls were HLA typed at the HLA-DRB1 and DQB1 loci. Clinical characteristics and hemodynamic parameters were reviewed. The patients with IPAH had a significantly higher frequency of the HLA-DRB1*0406 allele (18% vs. 6%, p = 0.004) and the HLA-DQB1*0302 allele (24% vs. 12%, p = 0.034), as well as a significantly higher frequency of haplotype DRB1*0406-DQB1*0302 (p = 0.0006). All 6 patients with haplotype DRB1*0406-DQB1*0302 (H+ group) were women, compared with 8 of the 13 patients lacking the DRB1*0406-DQB1*0302 haplotype (H- group), but without statistical significance. Three of 19 patients showed a positive short-term hemodynamic response to NO inhalation, all 3 of whom had the DRB1*0406-DQB1*0302 haplotype. There were no other significant differences in clinical characteristics and hemodynamic parameters between the H+ and H- groups. We conclude from this study that the HLA-DRB1*0406-DQB1*0302 haplotype is associated with IPAH in Korean patients. These results suggest that certain clinical characteristics of IPAH may be controlled in part by patients’ HLA alleles.
Literature
1.
go back to reference Barst RJ, Loyd JE (1998) Genetics and immunogenetic aspects of primary pulmonary hypertension. Chest 114(3 Suppl):231S–236SPubMed Barst RJ, Loyd JE (1998) Genetics and immunogenetic aspects of primary pulmonary hypertension. Chest 114(3 Suppl):231S–236SPubMed
3.
go back to reference Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SL, Levy PC, Reid LM, Vreim CE, Williams GW (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107:216–223PubMed Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, Fishman AP, Goldring RM, Groves BM, Koerner SL, Levy PC, Reid LM, Vreim CE, Williams GW (1987) Primary pulmonary hypertension. A national prospective study. Ann Intern Med 107:216–223PubMed
4.
go back to reference Rich S, Kieras K, Hart K, Groves BM, Stodo JD, Brundage BH (1986) Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 8:1307–1311PubMedCrossRef Rich S, Kieras K, Hart K, Groves BM, Stodo JD, Brundage BH (1986) Antinuclear antibodies in primary pulmonary hypertension. J Am Coll Cardiol 8:1307–1311PubMedCrossRef
5.
go back to reference Isern RA, Yaneva M, Weiner E, Parke A, Rothfield N, Dantzker D, Rich S, Arnett FC (1992) Autoantibodies in patients with primary pulmonary hypertension; association with anti-Ku. Am J Med 93:307–312PubMedCrossRef Isern RA, Yaneva M, Weiner E, Parke A, Rothfield N, Dantzker D, Rich S, Arnett FC (1992) Autoantibodies in patients with primary pulmonary hypertension; association with anti-Ku. Am J Med 93:307–312PubMedCrossRef
6.
go back to reference Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD (1990) Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322:1836–1841PubMedCrossRef Baisch JM, Weeks T, Giles R, Hoover M, Stastny P, Capra JD (1990) Analysis of HLA-DQ genotypes and susceptibility in insulin-dependent diabetes mellitus. N Engl J Med 322:1836–1841PubMedCrossRef
7.
go back to reference Barst RJ, Flaster ER, Menon A, Fotino M, Morse JH (1992) Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex. Circulation 85:249–258PubMed Barst RJ, Flaster ER, Menon A, Fotino M, Morse JH (1992) Evidence for the association of unexplained pulmonary hypertension in children with the major histocompatibility complex. Circulation 85:249–258PubMed
8.
go back to reference Langevitz P, Buskila D, Gladman DD, Darlington GA, Farewell VT, Lee P (1992) HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome. Br J Rheumatol 31:609–613PubMedCrossRef Langevitz P, Buskila D, Gladman DD, Darlington GA, Farewell VT, Lee P (1992) HLA alleles in systemic sclerosis: association with pulmonary hypertension and outcome. Br J Rheumatol 31:609–613PubMedCrossRef
9.
go back to reference Tanabe N, Kimura A, Amano S, Okada O, Kasahara Y, Tatsumi K, Takahashi M, Shibata H, Yasunami M, Kuriyama T (2005) Association of clinical features with HLA in chronic pulmonary thromboembolism. Eur Respir J 25:131–138PubMedCrossRef Tanabe N, Kimura A, Amano S, Okada O, Kasahara Y, Tatsumi K, Takahashi M, Shibata H, Yasunami M, Kuriyama T (2005) Association of clinical features with HLA in chronic pulmonary thromboembolism. Eur Respir J 25:131–138PubMedCrossRef
10.
go back to reference Powe JE, Palevsky HI, McCarthy KE, Alavi A (1987) Pulmonary arterial hypertension: value of perfusion scintigraphy. Radiology 164:727–730PubMed Powe JE, Palevsky HI, McCarthy KE, Alavi A (1987) Pulmonary arterial hypertension: value of perfusion scintigraphy. Radiology 164:727–730PubMed
11.
go back to reference Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132:919–923PubMed Guyatt GH, Sullivan MJ, Thompson PJ, Fallen EL, Pugsley SO, Taylor DW, Berman LB (1985) The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Can Med Assoc J 132:919–923PubMed
12.
go back to reference Hoeper MM, Maier R, Tongers J, Neidermeyer J, Hohlfeld JM, Hamm M, Fabel H (1999) Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 160:535–541PubMed Hoeper MM, Maier R, Tongers J, Neidermeyer J, Hohlfeld JM, Hamm M, Fabel H (1999) Determination of cardiac output by the Fick method, thermodilution, and acetylene rebreathing in pulmonary hypertension. Am J Respir Crit Care Med 160:535–541PubMed
13.
go back to reference Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV (2004) Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):35S–62SPubMedCrossRef Badesch DB, Abman SH, Ahearn GS, Barst RJ, McCrory DC, Simonneau G, McLaughlin VV (2004) Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 126(1 Suppl):35S–62SPubMedCrossRef
14.
go back to reference Park MH, Hwang YS, Park KS, Tokunaga K, Akaza T, Juji T, Kim SI (1998) HLA haplotypes in Koreans based on 107 families. Tissue Antigens 51:347–355PubMedCrossRef Park MH, Hwang YS, Park KS, Tokunaga K, Akaza T, Juji T, Kim SI (1998) HLA haplotypes in Koreans based on 107 families. Tissue Antigens 51:347–355PubMedCrossRef
15.
go back to reference Lane KB, Machado RD, Pauciulo MW, Thomson JR, Philips JA 3rd, Loyd JE, Nichols WC, Trembath RC (2000) Heterozygous germ-line mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26:81–84PubMedCrossRef Lane KB, Machado RD, Pauciulo MW, Thomson JR, Philips JA 3rd, Loyd JE, Nichols WC, Trembath RC (2000) Heterozygous germ-line mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. The International PPH Consortium. Nat Genet 26:81–84PubMedCrossRef
16.
go back to reference Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd, Newman J, Williams D, Galiè N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68:92–102PubMedCrossRef Machado RD, Pauciulo MW, Thomson JR, Lane KB, Morgan NV, Wheeler L, Phillips JA 3rd, Newman J, Williams D, Galiè N, Manes A, McNeil K, Yacoub M, Mikhail G, Rogers P, Corris P, Humbert M, Donnai D, Martensson G, Tranebjaerg L, Loyd JE, Trembath RC, Nichols WC (2001) BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension. Am J Hum Genet 68:92–102PubMedCrossRef
17.
go back to reference Newman JH, Wheeler L, Lane KB, Loyd E, Gaddipati R, Phillips JA 3rd, Loyd JE (2001) Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 345:319–324PubMedCrossRef Newman JH, Wheeler L, Lane KB, Loyd E, Gaddipati R, Phillips JA 3rd, Loyd JE (2001) Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred. N Engl J Med 345:319–324PubMedCrossRef
18.
go back to reference Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL (1984) Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70:580–587PubMed Fuster V, Steele PM, Edwards WD, Gersh BJ, McGoon MD, Frye RL (1984) Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation 70:580–587PubMed
19.
go back to reference Archer S, Rich S (2000) Primary pulmonary hypertension; A vascular biology and translational research “Work in Progress”. Circulation 102: 2781–2791PubMed Archer S, Rich S (2000) Primary pulmonary hypertension; A vascular biology and translational research “Work in Progress”. Circulation 102: 2781–2791PubMed
Metadata
Title
Association of HLA Class II Genes with Idiopathic Pulmonary Arterial Hypertension in Koreans
Authors
Sung-Ho Yoon
Heung-Bum Oh
Hyun-Kuk Kim
Suk-Chan Hong
Yeon-Mok Oh
Dong Soon Lee
Sang-Do Lee
Publication date
01-05-2007
Publisher
Springer-Verlag
Published in
Lung / Issue 3/2007
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-007-9006-1

Other articles of this Issue 3/2007

Lung 3/2007 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.